Filter
642
Text search:
Mild
COVID
Featured
Recommendations
112
New Publications
4
Language
Document type
Guidelines
250
Studies & Reports
134
Fact sheets
87
Manuals
57
Strategic & Response Plan
42
Situation Updates
23
Training Material
15
Infographics
10
Brochures
7
Resource Platforms
6
Videos
4
No document type
4
Online Courses
3
Countries / Regions
Global
34
India
29
South Africa
25
Germany
24
Syria
22
Western and Central Europe
22
Latin America and the Carribbean
21
Middle East and North Africa
18
Russia
18
Brazil
17
East and Southern Africa
15
West and Central Africa
15
Africa
15
Eastern Europe and Central Asia
14
Kenya
11
South–East Asia Region
10
South Sudan
9
Yemen
9
Bangladesh
7
Mozambique
6
Nigeria
5
Congo, Democratic Republic of
5
Angola
5
Western Pacific Region
5
Vietnam
5
Ethiopia
4
Jordan
4
Eastern Europe
4
United Kingdom
4
Guinea-Bissau
3
Ghana
3
Philippines
3
Lebanon
3
China
3
Malawi
3
Ukraine
3
Chile
3
Paraguay
3
Palestine
3
Tajikistan
3
Burkina Faso
2
Sierra Leone
2
Côte d’Ivoire / Ivory Coast
2
Zimbabwe
2
Nepal
2
Pakistan
2
Iraq
2
Afghanistan
2
Turkey
2
Cambodia
2
Colombia
2
Ecuador
2
Laos
2
Kazakhstan
2
Portugal
2
Liberia
1
Mali
1
Saudi Arabia
1
Uganda
1
Somalia
1
Egypt
1
Chad
1
Tanzania
1
Thailand
1
Rwanda
1
Singapore
1
Sudan
1
Benin
1
Argentina
1
Peru
1
Eswatini/ Swaziland
1
North Macedonia
1
Austria
1
Switzerland
1
Serbia
1
Bolivia
1
Myanmar / Burma
1
Sri Lanka
1
Asia
1
Fiji
1
Venezuela
1
Armenia
1
Congo-Brazzaville
1
Moldova
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Georgia
1
North America
1
France
1
Spain
1
South Korea
1
Authors & Publishers
Publication Years
Category
Countries
275
Clinical Guidelines
36
Public Health
26
Women & Child Health
22
Key Resources
16
Capacity Building
8
Pharmacy & Technologies
6
Toolboxes
COVID-19
457
NCDs
20
NTDs
13
Refugee
11
Malaria
11
Conflict
10
Planetary Health
10
Mental Health
9
Rapid Response
8
TB
8
Caregiver
8
HIV
7
Pharmacy
7
2.0 Rapid Response
7
AMR
6
Disability
5
Health Financing Toolbox
4
Natural Hazards
3
Cholera
2
Ebola & Marburg
1
Zika
1
Global Health Education
1
Risk Communication and Community Engagement messages
Coronavirus disease 2019 has a mild disease course in children and adolescents. Chronic respiratory conditions, including asthma, have been suggested as risk factors; however, asthma in children is highly variable in both triggers and severity.
Du
...
For COVID-19, as for many infectious diseases, the true level of transmission is frequently underestimated because a substantial proportion of people with the infection are undetected either because they are asymptomatic or have only
...
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, re
...
Published 24 January 2021
The term “Long COVID-19” covers a wide spectrum of symptoms that can occur or persist weeks and even months after an acute infection, not only after severe but also after initially
...
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, re
...
This document provides guidance on infection prevention and control (IPC) measures for people with suspected or confirmed coronavirus disease (COVID-19) who are experiencing mild symptoms that do no
...
Vaccines are designed to give you immunity without the dangers of getting the disease. It’s common to experience some mild to moderate side effects when receiving vaccinations. This is because your immune system instructs your body to increase blo
...
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, re
...
Coronavirus disease 2019 is also known as COVID-19. It is a viral illness that infects the lungs. It is caused by a virus called SARS-associated coronavirus (SARS-CoV-2). This illness was first seen in late 2019 in China and has spread across the wo
...
The Clinical Management of Patients with COVID-19 course series is developed for healthcare workers during the COVID-19 pandemic. The course provides crucial knowledge necessary to provide safe, eff
...
Этот документ представляет собой обновление
рекомендаций «Уход на дому за пациентами с легкой
формой заболевания COVID‑19 и тактика ведения
контактных лиц», опубл
...
Covid-19 Test to Treat Guidelines
recommended
n response to the outbreak, the Africa Centres for Disease Control and Prevention (Africa CDC) has been supporting African Union Member States in responding to the COVID-19 pandemic through a variety of interventions such as non-pharmaceutical inter
...
Ivermectin is an antiparasitic drug approved for the treatment of parasitic infections, including strongyloidiasis and onchocerciasis in humans. There is a reported increase in the use of ivermectin for the prevention and treatment of COVID-19 by th
...
31 March 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
...
Coronavirus disease 2019 (COVID-19) is an acute infectious respiratory disease caused by a newly discovered coronavirus (SARS-CoV-2).
Most people infected with the COVID-19 virus experience
...
It is intended for use among clinicians taking care of moderate to severe COVID-19 cases.
The COVID-19 outbreak has brought with it the need for improved critical care for patients who develop seve
...
Wearing a face mask can help reduce the spread of COVID-19 in the community by reducing the release of respiratory droplets from asymptomatic / pre-symptomatic individuals or those with mild non-spe
...
